IP Library Granted Patent US 7,666,987
Granted Patent B2
US 7,666,987 · App. 11/347,054 · Granted Feb 23, 2010

Bioluminescent caspase assay compounds

Assignee: Promega Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,666,987
App. No.
11/347,054
Granted
Feb 23, 2010
Kind
B2
Abstract

A sensitive bioluminescent assay to detect proteases including caspases is provided which employs an aminoluciferin or a carboxy-terminal protected derivative thereof covalently linked via a peptide bond to a substrate for a caspase or an aminoluciferin or a carboxy-terminal protected derivative thereof covalently linked via a peptide bond to a peptide substrate comprising aspartate that is specifically cleaved by a protease specific for the substrate.

Claims (13)

1. A compound comprising aminoluciferin or a carboxy-terminal protected derivative thereof covalently linked via a peptide bond to a substrate for a caspase, wherein the compound is a substrate for a caspase and a prosubstrate for a beetle luciferase, wherein the substrate comprises X 1 -X 2 -X 3 -D, wherein X 1 is Y, D, L, V, I, A, W, or P; X 2 is V or E; and X 3 is any amino acid.

2. The compound of claim 1 wherein the substrate comprises DEVD (SEQ ID NO:1).

3. The compound of claim 1 wherein the substrate comprises YVAD (SEQ ID NO:2).

4. The compound of claim 1 wherein the substrate comprises LEHD (SEQ ID NO:3).

5. The compound of claim 1 wherein X 3 is A, V, H, I, or T.

6. The compound of claim 1 which is a carboxy-terminal protected derivative of aminoluciferin.

7. The compound of claim 6 wherein the carboxy-terminus is protected as a (C 1 -C 6 )alkyl ester.

8. The compound of claim 6 , wherein the carboxy-terminus is protected as a methyl, ethyl, propyl, or tert-butyl ester.

9. The compound of claim 6 wherein the N-terminus of the substrate is modified to prevent degradation by aminopeptidases.

10. The compound of claim 9 wherein the N-terminus of the substrate is modified with an amino protecting group.

11. The compound of claim 9 wherein the carboxy-terminus is protected by coupling to a solid support.

12. The compound of claim 1 wherein the substrate is DEVD (SEQ ID NO:1).

13. The compound of claim 1 wherein the substrate is X 1 -X 2 -X 3 -D, wherein X 1 is Y, D, L, V, I, A, W, or P; X 2 is V or E; and X 3 is any amino acid.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: O'BRIEN, MARTHA; WOOD, KEITH V.; KLAUBERT, DIETER; DAILY, WILLIAM
To: PROMEGA CORPORATION
Reel/Frame 033212/0620 →
Continuity (3)
Division 1035666500 · Jan 31, 2003
Provisional Application 6035315800 · Feb 1, 2002
Related Publication 20060121546A1 · Jun 8, 2006